A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer.
Cagney DN, Thirion PG, Dunne MT, Fleming C, Fitzpatrick D, O'Shea CM, Finn MA, O'Sullivan S, Booth C, Collins CD, Buckney SJ, Shannon A, Armstrong JG.
Cagney DN, et al. Among authors: buckney sj.
Clin Oncol (R Coll Radiol). 2018 Jan;30(1):30-38. doi: 10.1016/j.clon.2017.10.010. Epub 2017 Oct 31.
Clin Oncol (R Coll Radiol). 2018.
PMID: 29097074
Clinical Trial.